Ritter Pharmaceuticals basically dead? Satış

Açıklama

⋅ 13 Eyl 2019 13:05

-75% Ritter Pharmaceuticals Inc -after the company's Phase 3 trial of RP-G28 for lactose intolerance failed to demonstrate statistical significance in its pre-specified endpoint

Daha Fazla